Experimental designs and their recent advances in set-up, data interpretation, and analytical applications

Journal of Pharmaceutical and Biomedical Analysis

Volumn 56, Issue 2, 2011, Pages 141-158

  Dejaegher, Bieke ^a   Vander Heyden, Yvan ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

Design applications; Design data interpretation; Design set up; Experimental design

Indexed keywords

ALGORITHM; DRUG IMPURITY; EXPERIMENTAL DESIGN; EXPERIMENTAL MODEL; FACTORIAL DESIGN; PRIORITY JOURNAL; PROCESS OPTIMIZATION; RESPONSE SURFACE METHOD; REVIEW; SCREENING; STATISTICAL ANALYSIS;

ALGORITHMS; CHEMISTRY, PHARMACEUTICAL; DATA INTERPRETATION, STATISTICAL; DRUG COMPOUNDING; DRUG CONTAMINATION; FACTOR ANALYSIS, STATISTICAL; HIGH-THROUGHPUT SCREENING ASSAYS; MODELS, STATISTICAL; PHARMACEUTICAL PREPARATIONS; RESEARCH DESIGN; TECHNOLOGY, PHARMACEUTICAL;

EID: 79960049840     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2011.04.023     Document Type: Review

References (125)

1. Massart D.L., Vandeginste B.G.M., Buydens L.M.C., De Jong S., Lewi P.J., Smeyers-Verbeke J. Handbook of Chemometrics and Qualimetrics: Part A 1997, Elsevier, Amsterdam.
2. Vander Heyden Y., Perrin C., Massart D.L. Optimization strategies for HPLC and CZE. Handbook of Analytical Separations, vol. 1, Separation Methods in Drug Synthesis and Purification 2000, 163-212. Elsevier, Amsterdam. K. Valkó (Ed.).
3. Dejaegher B., Vander Heyden Y. Sequential optimization methods. Comprehensive Chemometrics 2009, vol. 1:547-575. Elsevier, Oxford, (Chapter 17).
4. Dejaegher B., Vander Heyden Y. The use of experimental design in separation science. Acta Chromatogr. 2009, 21:161-201.
5. Dejaegher B., Durand A., Vander Heyden Y. Experimental design in method optimization and robustness testing. Chemometric Methods in Capillary Electrophoresis 2010, 11-74. John Wiley & Sons, New Jersey, (Chapter 2). G. Hanrahan, F.A. Gomez (Eds.).
6. Montgomery D.C. Design and Analysis of Experiments 1997, John Wiley, New York. 4th edition.
7. Dejaegher B., Vander Heyden Y. Robustness tests of CE methods. Capillary Electrophoresis Methods for Pharmaceutical Analysis 2008, 185-224. Elsevier, Amsterdam, (Chapter 9). M. Jimidar, S. Ahuja (Eds.).
8. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM), Office of Regulatory Affairs (ORA), Pharmaceutical CGMPs, 2004, Guidance for Industry: Process Analytical Technologies (PAT) - a framework for Innovative Pharmaceutical and Food Development, Manufacturing and Quality Assurance. accessed on October 22nd 2010. http://www.fda.gov/.
9. Lewis G.A., Mathieu D., Phan-Tan-Luu R. Pharmaceutical Experimental Design 1999, Marcel Dekker, New York.
10. Vander Heyden Y., Massart D.L. Review of the use of robustness and ruggedness in analytical chemistry. Robustness of Analytical Chemical Methods and Pharmaceutical Technological Products 1996, 79-147. Elsevier, Amsterdam, (Chapter 3). M.W.B. Hendriks, J.H. de Boer, A.K. Smilde (Eds.).
11. Dejaegher B., Vander Heyden Y. Ruggedness and robustness testing. J. Chromatogr. A 2007, 1158:138-157.
12. Plackett R.L., Burman J.P. The design of optimum multifactorial experiments. Biometrika 1946, 33:302-325.
13. Vander Heyden Y., Khots M.S., Massart D.L. Three-level screening designs for the optimisation or the ruggedness testing of analytical procedures. Anal. Chim. Acta 1993, 276:189-195.
14. Addelman S. Orthogonal main-effect plans for asymmetrical factorial experiments. Technometrics 1962, 4:21-46.
15. Hund E., Vander Heyden Y., Haustein M., Massart D.L., Smeyers-Verbeke J. Comparison of several criteria to decide on the significance of effects in a robustness test with an asymmetrical factorial design. Anal. Chim. Acta 2000, 404:257-271.
16. Hund E., Vander Heyden Y., Haustein M., Massart D.L., Smeyers-Verbeke J. Robustness testing of a reversed-phase high-performance liquid chromatographic assay: comparison of fractional and asymmetrical factorial designs. J. Chromatogr. A 2000, 874:167-185.
17. Perrin C., Fabre H., Massart D.L., Vander Heyden Y. Influence of peak measurement parameters on the quality of chiral electrophoretic separations. Electrophoresis 2003, 24:2469-2480.
18. Dejaegher B., Vander Heyden Y. Supersaturated designs: set-ups, data interpretations and analytical applications. Anal. Bioanal. Chem. 2008, 390:1227-1240.
19. Vander Heyden Y., Kuttatharmmakul S., Smeyers-Verbeke J., Massart D.L. Supersaturated designs for robustness testing. Anal. Chem. 2000, 72:2869-2874.
20. Dejaegher B., Smeyers-Verbeke J., Vander Heyden Y. The variance of screening and supersaturated design results as a measure for method robustness. Anal. Chim. Acta 2005, 544:268-279.
21. Dejaegher B., Capron X., Vander Heyden Y. Fixing effects and adding rows (FEAR) method to estimate factor effects in supersaturated designs constructed from Plackett-Burman designs. Chemom. Intell. Lab. Syst. 2007, 85:220-231.
22. Dejaegher B., Capron X., Vander Heyden Y. Generalized FEAR method to estimate factor effects in two-level supersaturated designs. J. Chemom. 2007, 21:303-323.
23. Satterthwaite F.E. Random balance experimentation (with discussion). Technometrics 1959, 1:111-137.
24. Booth K.H.V., Cox D.R. Some systematic supersaturated designs. Technometrics 1962, 4:489-495.
25. Lin D.K.J. Generating systematic supersaturated designs. Technometrics 1995, 37:213-225.
26. 2 optimality. Can. J. Stat. 1997, 25:191-201.
27. Lin D.K.J. A new class of supersaturated designs. Technometrics 1993, 35:28-31.
28. Li W.W., Wu C.F.J. Columnwise-pairwise algorithms with applications to the construction of supersaturated designs. Technometrics 1997, 39:171-179.
29. Cela R., Martínez E., Carro A.M. Supersaturated experimental designs: new approaches to building and using it: part I. Building optimal supersaturated designs by means of evolutionary algorithms. Chemom. Intell. Lab. Syst. 2000, 52:167-182.
30. Lu X., Meng Y. A new method in the construction of two-level supersaturated designs. J. Stat. Plan. Infer. 2000, 86:229-238.
31. Liu M., Zhang R. Construction of Es2 optimal supersaturated designs using cyclic BIBDs. J. Stat. Plan. Infer. 2000, 91:139-150.
32. Nguyen N.-K. An algorithmic approach to constructing supersaturated designs. Technometrics 1996, 38:69-73.
33. Fang K.-T., Lin D.K.J., Qin H. A note on optimal foldover design. Stat. Probab. Lett. 2003, 62:245-250.
34. Jones B., Lin D.K.J., Nachtsheim C.J. Bayesian D-optimal supersaturated designs. J. Stat. Plan. Infer. 2008, 138:86-92.
35. Allen T.T., Bernshteyn M. Supersaturated designs that maximize the probability of identifying active factors. Technometrics 2003, 45:90-97.
36. Beattie S.D., Fong D.K.H., Lin D.K.J. A two-stage bayesian model selection strategy for supersaturated designs. Technometrics 2002, 44:55-63.
37. Yamada S., Lin D.K.J. Three-level supersaturated designs. Stat. Probab. Lett. 1999, 45:31-39.
38. Yamada S., Ikebe Y.T., Hashiguchi H., Niki N. Construction of three-level supersaturated design. J. Stat. Plan. Infer. 1999, 81:183-193.
39. Fang K.-T., Lin D.K.J., Ma C.-X. On the construction of multi-level supersaturated designs. J. Stat. Plan. Infer. 2000, 86:239-252.
40. Lu X., Hu W., Zheng Y. A systematical procedure in the construction of multi-level supersaturated designs. J. Stat. Plan. Infer. 2003, 115:287-310.
41. Aggarwal M.L., Gupta S. A new method of construction of multi-level supersaturated designs. J. Stat. Plan. Infer. 2004, 121:127-134.
42. Yamada S., Matsui T. Optimality of mixed-level supersaturated designs. J. Stat. Plan. Infer. 2002, 104:459-468.
43. Yamada S., Lin D.K.J. Construction of mixed-level supersaturated designs. Metrika 2002, 56:205-214.
44. Fang K.-T., Lin D.K.J., Liu M.-Q. Optimal mixed-level supersaturated designs. Metrika 2003, 58:279-291.
45. Li P.-F., Liu M.-Q., Zhang R.-C. Some theory and the construction of mixed-level supersaturated designs. Stat. Probab. Lett. 2004, 69:105-116.
46. Box G.E.P., Behnken D.W. Simplex-sum designs: a class of second order rotatable designs derivable from those of first order. Ann. Math. Stat. 1960, 31:838-864.
47. Doehlert D.H. Uniform shell designs. Appl. Stat. 1970, 19:231-239.
48. de Aguiar P.F., Bourguignon B., Khots M.S., Massart D.L., Phan-Than-Luu R. D-optimal designs. Chemom. Intell. Lab. Syst. 1995, 30:199-210.
49. Kennard R.W., Stone L.A. Computer aided design of experiments. Technometrics 1969, 11:137-148.
50. Dong F. On the identification of active contrasts in unreplicated fractional factorials. Stat. Sin. 1993, 3:209-217.
51. Dejaegher B., Capron X., Smeyers-Verbeke J., Vander Heyden Y. Randomization tests to identify significant effects in experimental designs for robustness testing. Anal. Chim. Acta 2006, 564:184-200.
52. Dejaegher B., Durand A., Vander Heyden Y. Identification of significant effects from an experimental screening design in the absence of effect sparsity. J. Chromatogr. B 2009, 877:2252-2261.
53. Cela R., Martínez E., Carro A.M. Supersaturated experimental designs: new approaches to building and using it: part II. Solving supersaturated designs by genetic algorithms. Chemom. Intell. Lab. Syst. 2001, 57:75-92.
54. Rais F., Kamoun A., Chaabouni M., Claeys-Bruno M., Phan-Tan-Luu R., Sergent M. Supersaturated design for screening factors influencing the preparation of sulfated amides of olive pomace oil fatty acids. Chemom. Intell. Lab. Syst. 2009, 99:71-78.
55. Bezerra M.A., Santelli R.E., Oliviera E.P., Villar L.S., Escaleira L.A. Response surface methodology (RSM) as a tool for optimization in analytical chemistry. Talanta 2008, 76:965-977.
56. Ferreira S.L.C., dos Santos W.N.L., Quintella C.M., Neto B.B., Bosque-Sendra J.M. Doehlert matrix: a chemometric tool for analytical chemistry - review. Talanta 2004, 63:1061-1067.
57. Maia P.P., Amaya-Farfán J., Rath S., Reyes F.G.R. Simultaneous determination of streptomycin and oxytetracycline in agricultural antimicrobials by CZE after an experimental design. J. Pharm. Biomed. Anal. 2007, 43:450-456.
58. Tobback K., Li Y.-M., Pizarro N.A., De Smedt I., Smeets T., Van Schepdael A., Roets E., Hoogmartens J. Micellar electrokinetic capillary chromatography of macrolide antibiotics: separation of tylosin, erythromycin and their related substances. J. Chromatogr. A 1999, 857:313-320.
59. Orwa J.A., Bosmans F., Depuydt S., Roets E., Hoogmartens J. Liquid chromatographic method for separation of lincomycin from its related substances. J. Chromatogr. A 1998, 829:161-166.
60. Orwa J.A., Vandenbempt K., Depuydt S., Roets E., Hoogmartens J. Liquid chromatography method for separation of clindamycin from related substances. J. Pharm. Biomed. Anal. 1999, 20:745-752.
61. Lara F.J., García-Campaña A.M., Alés-Barrero F., Bosque-Sendra J.M., Garciá-Ayuso L.E. Multiresidue method for the determination of quinolone antibiotics in bovine raw milk by capillary electrophoresis-tandem mass spectrometry. Anal. Chem. 2006, 78:7665-7673.
62. Schappler J., Guillarme D., Prat J., Veuthey J.-L., Rudaz S. Coupling CE with atmospheric pressure photoionization MS for pharmaceutical basic compounds: optimization of operating parameters. Electrophoresis 2007, 28:3078-3087.
63. Altria K.D., Bryant S.M., Hadgett T.A. Validated capillary electrophoresis method for the analysis of a range of acidic drugs and excipients. J. Pharm. Biomed. Anal. 1997, 15:1091-1101.
64. Kristoffersen L., Bugge A., Lundanes E., Slordal L. Simultaneous determination of citalopram, fluoxetine, paroxetine and their metabolites in plasma and whole blood by high-performance liquid chromatography with ultraviolet and fluorescence detection. J. Chromatogr. B 1999, 734:229-246.
65. Yekkala R.S., Vandenwayenberg S., Hoogmartens J., Adams E. Evaluation of an International Pharmacopoeia method for the analysis of nelfinavir mesilate by liquid chromatography. J. Chromatogr. A 2006, 1134:56-65.
66. Thorsteinsdóttir M., Westerlund D., Andersson G., Kaufmann P. Chemometric evaluation of the band broadening in micellar electrokinetic chromatography of peptides. J. Chromatogr. A 1998, 809:191-201.
67. Gotti R., Furlanetto S., Andrisano V., Cavrini V., Pinzauti S. Design of experiments for capillary electrophoretic enantioresolution of salbutamol using dermatan sulfate. J. Chromatogr. A 2000, 875:411-422.
68. Furlanetto S., Orlandini S., La Porta E., Coran S., Pinzauti S. Optimization and validation of a CZE method for rufloxacin hydrochloride determination in coated tablets. J. Pharm. Biomed. Anal. 2002, 28:1161-1171.
69. Orlandini S., Fanali S., Furlanetto S., Marras A.M., Pinzauti S. Micellar electrokinetic chromatography for the simultaneous determination of ketorolac tromethamine and its impurities: multivariate optimization and validation. J. Chromatogr. A 2004, 1032:253-263.
70. Gotti R., Furlanetto S., Pinzauti S., Cavrini V. Analysis of catechins in Theobroma cacao beans by cyclodextrin-modified micellar electrokinetic chromatography. J. Chromatogr. A 2006, 1112:345-352.
71. Berzas-Nevado J.J., Villaseñor-Llerena M.J., Guiberteau-Cabanillas C., Rodríguez-Robledo V. Enantiomeric screening of racemic citalopram and metabolites in human urine by entangled polymer solution capillary electrophoresis: an innovatory robustness/ruggedness study. Electrophoresis 2006, 27:905-917.
72. Ficarra R., Ficarra P., Tommasini S., Melardi S., Calabrò M.L., Furlanetto S., Semreen M. Validation of a LC method for the analysis of zafirlukast in a pharmaceutical formulation. J. Pharm. Biomed. Anal. 2000, 23:169-174.
73. Rodríguez Flores J., Berzas Nevado J.J., Contento Salcedo A.M., Cabello Díaz M.P. Nonaqueous capillary electrophoresis method for the analysis of tamoxifen, imipramine and their main metabolites in urine. Talanta 2005, 65:155-162.
74. Berzas Nevado J.J., Rodríguez Flores J., Castañeda Peñalvo G., Guzmán Bernardo F.J. Development and validation of a capillary zone electrophoresis method for the determination of propranolol and N-desisopropylpropranolol in human urine. Anal. Chim. Acta 2006, 559:9-14.
75. Yongxin Z., Verhasselt A., Roets E., Perez A., Porqueras E., Hoogmartens J. Evaluation of liquid chromatography methods for the analysis of benzylpenicillin and its related substances. J. Chromatogr. A 1997, 773:147-156.
76. Hillaert S., Snoeck L., Van den Bossche W. Optimization and validation of a capillary zone electrophoretic method for the simultaneous analysis of four atypical antipsychotics. J. Chromatogr. A 2004, 1033:357-362.
77. Capella-Peiró M.E., Bossi A., Esteve-Romero J. Optimization by factorial design of a capillary zone electrophoresis method for the simultaneous separation of antihistamines. Anal. Biochem. 2006, 352:41-49.
78. Ficarra R., Cutroneo P., Aturki Z., Tommasini S., Calabrò M.L., Phan-Tan-Luu R., Fanali S., Ficarra P. An experimental design methodology applied to the enantioseparation of a non-steroidal anti-inflammatory drug candidate. J. Pharm. Biomed. Anal. 2002, 29:989-997.
79. Galeano-Díaz T., Acedo-Valenzuela M.-I., Mora-Díez N., Silva-Rodríguez A. Response surface methodology in the development of a stacking-sensitive capillary electrophoresis method for the analysis of tricyclic antidepressants in human serum. Electrophoresis 2005, 26:3518-3527.
80. Harang V., Tysk M., Westerlund D., Isaksson R., Johansson G. A statistical experimental design to study factors affecting enantioseparation of propranolol by capillary electrophoresis with cellobiohydrolase (Cel7A) as chiral selector. Electrophoresis 2002, 23:2306-2319.
81. Montes R.E., Hanrahan G., Gomez F.A. Use of chemometric methodology in optimizing conditions for competitive binding partial filling affinity capillary electrophoresis. Electrophoresis 2008, 29:3325-3332.
82. Lara F.J., García-Campaña A.M., Gámiz-Gracia L., Bosque-Sendra J.M., Alés-Barrero F. Determination of phenothiazines in pharmaceutical formulations and human urine using capillary electrophoresis with chemiluminescence detection. Electrophoresis 2006, 27:2348-2359.
83. Jimidar M., de Aguiar P.F., Pintelon S., Massart D.L. Selectivity optimization for the separation of chlorophenols in an irregularly shaped experimental region in capillary electrophoresis. J. Pharm. Biomed. Anal. 1997, 15:709-728.
84. Fradi I., Servais A.-C., Pedrini M., Chiap P., Iványi R., Crommen J., Fillet M. Enantiomeric separation of acidic compounds using single-isomer amino cyclodextrin derivatives in nonaqueous capillary electrophoresis. Electrophoresis 2006, 27:3434-3442.
85. de Aguiar P.F., Bourguignon B., Massart D.L. Comparison of models and designs for optimization of the pH and solvent strength in HPLC. Anal. Chim. Acta 1997, 356:7-18.
86. Torres-Lapasió J.R., Massart D.L., Baeza-Baeza J.J., García-Alvarez-Coque M.C. A three-factor optimisation strategy for micellar liquid chromatography. Chromatographia 2000, 51:101-110.
87. Y. Vander Heyden, Some frequent problems occurring in method optimisation in pharmaceutical analysis, LC-GC Europe, in press.
88. Pages G., Delaurant C., Phan-Tan-Luu R., Sergent M. Different chemometric approaches to optimize the assay of St. John's Wort active ingredients. Chemom. Intell. Lab. Syst. 2007, 86:159-167.
89. European Pharmacopoeia, 5th edition, Council of Europe, Strasbourg, France, 2004, pp. 112-113.
90. Derakhshandeh K., Erfan M., Dadashzadeh S. Encapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: factorial design, characterization and release kinetics. Eur. J. Pharm. Biopharm. 2007, 66:34-41.
91. Stensrud G., Sande S.A., Kristensen S., Smistad G. Formulation and characterisation of primaquine loaded liposomes prepared by a pH gradient using experimental design. Int. J. Pharm. 2000, 198:213-228.
92. Tajber L., Corrigan O.I., Healy A.M. Spray drying of budesonide, formoterol fumarate and their composites-II. Statistical factorial design and in vitro deposition properties. Int. J. Pharm. 2009, 367:86-96.
93. Reddy L.V.A., Wee Y.-J., Yun J.-S., Ryu H.-W. Optimization of alkaline protease production by batch culture of Bacillus sp. RKY3 through Plackett-Burman and response surface methodological approaches. Bioresour. Technol. 2008, 99:2242-2249.
94. Ahuja M., Yadav M., Kumar S. Application of response surface methodology to formulation of ionotropically gelled gum cordia/gellan beads. Carbohydr. Polym. 2010, 80:161-167.
95. Rahman Z., Zidan A.S., Habib M.J., Khan M.A. Understanding the quality of protein loaded PLGA nanoparticles variability by Plackett-Burman design. Int. J. Pharm. 2010, 389:186-194.
96. Padamwar M.N., Pokharkar V.B. Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability. Int. J. Pharm. 2006, 320:37-44.
97. Cafaggi S., Leardi R., Parodi B., Caviglioli G., Russo E., Bignardi G. Preparation and evaluation of a chitosan salt-poloxamer 407 based matrix for buccal drug delivery. J. Control. Release 2005, 102:159-169.
98. Mignani A., Luciano G., Lanteri S., Leardi R., Scavetta E., Tonelli D. Optimization of a glucose biosensor setup based on a Ni/Al HT matrix. Anal. Chim. Acta 2007, 599:36-40.
99. Imandi S.B., Bandaru V.V.R., Somalanka S.R., Garapati H.R. Optimization of medium constituents for the production of citric acid from byproduct glycerol using Doehlert experimental design. Enzyme Microb. Technol. 2007, 40:1367-1372.
100. Cafaggi S., Russo E., Stefani R., Leardi R., Caviglioli G., Parodi B., Bignardi G., De Totero D., Aiello C., Viale M. Preparation and evaluation of nanoparticles made of chitosan or N-trimethyl chitosan and a cisplatin-alginate complex. J. Control. Release 2007, 121:110-123.
101. Cano C.B., Felsner M.L., Bruns R.E., Matos J.R., Almeida-Muradian L.B. Optimization of mobile phase for separation of carbohydrates in honey by high performance liquid chromatography using a mixture design. J. Braz. Chem. Soc. 2006, 17:588-593.
102. Borges C.N., Bruns R.E., Almeida A.A., Scarminio I.S. Mixture-mixture design for the fingerprint optimization of chromatographic mobile phases and extraction solutions for Camellia sinensis. Anal. Chim. Acta 2007, 595:28-37.
103. Delaroza F., Scarminio I.S. Mixture design optimization of extraction and mobile phase media for fingerprint analysis of Bauhinia variegata L. J. Sep. Sci. 2008, 31:1034-1041.
104. Zhu W., Yu A., Wang W., Dong R., Wu J., Zhai G. Formulation design of microemulsion for dermal delivery of penciclovir. Int. J. Pharm. 2008, 360:184-190.
105. Choisnard L., Géze A., Bigan M., Putaux J.-L., Wouessidjewe D. Efficient size control of amphiphilic cyclodextrin nanoparticles through a statistical mixture design methodology. J. Pharm. Pharm. Sci. 2005, 8:560-593.
106. Cafaggi S., Leardi R., Parodi B., Caviglioli G., Bignardi G. An example of application of a mixture design with constraints to a pharmaceutical formulation. Chemom. Intell. Lab. Syst. 2003, 65:139-147.
107. De Beer T.R.M., Bodson C., Dejaegher B., Walczak B., Vercruysse P., Burggraeve A., Lemos A., Delattre L., Vander Heyden Y., Remon J.P., Vervaet C., Baeyens W.R.G. Raman spectroscopy as a process analytical technology (PAT) tool for the in-line monitoring and understanding of a powder blending process. J. Pharm. Biomed. Anal. 2008, 48:772-779.
108. De Beer T.R.M., Baeyens W.R.G., Ouyang J., Vervaet C., Remon J.P. Raman spectroscopy as a process analytical technology tool for the understanding and the quantitative in-line monitoring of the homogenization process of a pharmaceutical suspension. Analyst 2006, 131:1137-1144.
109. De Beer T.R.M., Alleso M., Goethals F., Coppens A., Vander Heyden Y., Lopez De Diego H., Rantanen J., Verpoort F., Vervaet C., Remon J.P., Baeyens W.R.G. Implementation of a process analytical technology system in a freeze-drying process using Raman spectroscopy for in-line process monitoring. Anal. Chem. 2007, 79:7992-8003.
110. Burggraeve A., Van Den Kerkhof T., Hellings M., Remon J.P., Vervaet C., De Beer T. Evaluation of in-line spatial filter velocimetry as PAT monitoring tool for particle growth during fluid bed granulation. Eur. J. Pharm. Biopharm. 2010, 76:138-146.
111. International Conference on Harmonisation of Technical Requirements for the Registration of Pharmaceuticals for Human Use (ICH) guideline Q3A(R2), Impurities in new drug substances, 2006, accessed on October 6th 2010. http://www.ich.org/.
112. Ferguson P.D., Szucs R., Hailey P.A., Loran J.S., Wicks S.A. 26th Annual BMSS Meeting 2002.
113. Dumarey M., Sneyers R., Janssens W., Somers I., Vander Heyden Y. Drug impurity profiling: method optimization on dissimilar chromatographic systems: part I: pH optimization of the aqueous phase. Anal. Chim. Acta 2009, 656:85-92.
114. Dejaegher B., Dumarey M., Vander Heyden Y. Method development for drug impurity profiling - part I. LC-GC Eur. 2010, 23:218-224.
115. Dejaegher B., Dumarey M., Vander Heyden Y. Method development for drug impurity profiling - part II. LC-GC Eur. 2010, 23:536-542.
116. Vassort A., Barrett D.A., Shaw P.N., Ferguson P.D., Szucs R. A generic approach to the impurity profiling of drugs using standardised and independent capillary zone electrophoresis methods coupled to electrospray ionisation mass spectrometry. Electrophoresis 2005, 26:1712-1723.
117. Vassort A., Shaw P.N., Ferguson P.D., Szücs R., Barrett D.A. Comparison of CZE, open-tubular CEC and non-aqueous CE coupled to electrospray MS for impurity profiling of drugs. Electrophoresis 2008, 29:3563-3574.
118. Martinez E., Cela R., Carro A.M., Cobas J.C., García B. Chemometrically guided sample composition for fast screening of trace metals in water samples. J. Anal. At. Spectrom. 2002, 17:1373-1380.
119. Pensado L., Blanco E., Casais M.C., Mejuto M.C., Martinez E., Carro A.M., Cela R. Strategic sample composition in the screening of polycyclic aromatic hydrocarbons in drinking water samples using liquid chromatography with fluorimetric detection. J. Chromatogr. A 2004, 1056:121-130.
120. Carpinteiro J., Quintana J.B., Martínez E., Rodríguez I., Carro A.M., Lorenzo R.A., Cela R. Application of strategic sample composition to the screening of anti-inflammatory drugs in water samples using solid-phase microextraction. Anal. Chim. Acta 2004, 524:63-71.
121. Rodil R., Martínez E., Carro A.M., Lorenzo R.A., Cela R. Applying supersaturated experimental designs to the study of composite sampling for monitoring pesticide residues in water. LC-GC North Am. 2004, 22:272-286.
122. Martinez E., Landin P., Carro A.M., Llompart M.P., Cela R. Strategically designed sample composition for fastest screening of polychlorinated biphenyl congeners in water samples. J. Environ. Monit. 2002, 4:490-497.
123. Martínez E., Pazos M., Carro A.M., Llompart M., Cela R. Application of strategically designed sample composition to the rapid analytical screening of milk samples for polychlorinated biphenyls. J. AOAC Int. 2003, 86:846-855.
124. Phan-Tan-Luu R., Sergent M. Course notes on 'Methodologie de la Recherche Expérimentale: Nouveaux outils de planification expérimentale' 2006.
125. Dejaegher B., Dumarey M., Capron X., Bloomfield M.S., Vander Heyden Y. Comparison of Plackett-Burman and supersaturated designs in robustness testing. Anal. Chim. Acta 2007, 595:59-71.